BioCentury
ARTICLE | Clinical News

Taligen Therapeutics preclinical data

October 6, 2008 7:00 AM UTC

In a mouse heterotopic heart transplant model, TT32 protected grafts from ischemia reperfusion injury (IRI) as assessed by histology, C3 deposition, and a reduction in neutrophils and inflammatory cyt...